Bafna Pharmaceuticals Limited (NSE:BAFNAPH)

India flag India · Delayed Price · Currency is INR
131.84
-1.13 (-0.85%)
Apr 29, 2026, 3:29 PM IST
63.98%
Market Cap 3.15B
Revenue (ttm) 1.47B
Net Income (ttm) 96.61M
Shares Out 23.66M
EPS (ttm) 4.09
PE Ratio 32.53
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,210
Average Volume 4,945
Open 138.80
Previous Close 132.97
Day's Range 130.55 - 138.80
52-Week Range 71.57 - 202.06
Beta -0.02
RSI 56.04
Earnings Date May 26, 2026

About Bafna Pharmaceuticals

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. It also exports its products to Europe, the United Kingdom, Australia, Sri Lanka, Africa, Philippines, Tanzania, Nigeria, and Commonwealth countries. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India. Bafna Pharmaceuticals Limited is a subsidiary of SRJR Lifesciences LLP. [Read more]

Sector Healthcare
Founded 1981
Employees 406
Stock Exchange National Stock Exchange of India
Ticker Symbol BAFNAPH
Full Company Profile

Financial Performance

In fiscal year 2025, Bafna Pharmaceuticals's revenue was 1.46 billion, a decrease of -4.33% compared to the previous year's 1.52 billion. Earnings were 41.53 million, a decrease of -43.49%.

Financial Statements

News

There is no news available yet.